N-Methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat

Neuroscience Letters

Volumn 265, Issue 3, 1999, Pages 187-190

  Mazarati, Andrey M ^a,b   Wasterlain, Claude G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

AMPA kainate receptor; Anticonvulsant effects; Blockers; Hippocampus; N methyl D asparate receptor; Self sustaining status epilepticus

Indexed keywords

5,7 DICHLOROKYNURENIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; KETAJET; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; ELECTROSTIMULATION; EPILEPTIC DISCHARGE; EPILEPTIC STATE; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PERFORANT NERVE TRACT; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SPIKE;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; KETAMINE; KYNURENIC ACID; MALE; PERFORANT PATHWAY; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; STATUS EPILEPTICUS;

EID: 0033597091     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00238-4     Document Type: Article

References (17)

1. Drake C.T., Terman G.W., Simmons M.L., Milner T.A., Kunkel D.D., Schwartzkroin P.A., Chavkin C. Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters. J. Neurosci. 14:1994;3736-3750.
2. Kapur J., Coulter D.A. Experimental status epilepticus alters GABAA receptor function in CA1 pyramidal neurons. Ann. Neurol. 38:1995;893-900.
3. 2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J. Neurosci. 17:1997;7532-7540.
4. Liu H., Mantyh P.W., Basbaum A.I. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature. 386:1997;721-724.
5. Liu H., Mazarati A.M., Katsumori H., Wasterlain C.G. Limbic seizures mediated by phenotypic switch in hippocampal principal neurons. Soc. Neurosci. Abstr. 24:1998;2140.
6. Lothman E.W., Bertram E.H., Bekenstein J.W., Perlin J.B. Self-sustaining limbic status epilepticus induced by 'continuous' hippocampal stimulation: electrographic and behavioral characteristics. Epilepsy Res. 3:1989;107-119.
7. Mazarati A.M., Baldwin R.A., Sankar R., Wasterlain C. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res. 814:1998;179-185.
8. Mazarati A.M., Liu H., Langel U., Soomets U., Sankar R., Shin D., Wasterlain C.G. Galanin modulation of seizures and seizure modulation of hippocampal galanin in an animal model of status epilepticus. J. Neurosci. 18:1998;10070-10077.
9. Mazarati A.M., Wasterlain C.G. Loss of hippocampal inhibition and enhanced LTP after self-sustaining status epilepticus. Epilepsia. 38:(Suppl. 3):1997;178.
10. Mazarati A.M., Wasterlain C.G., Liu H. Opioid peptides pharmacology and immunochemistry after self- sustaining status epilepticus. Neuroscience. 89:1999;167-173.
11. Mazarati A.M., Wasterlain C.G., Sankar R., Shin D. Self- sustaining status epilepticus after brief electrical stimulation of the perforant path. Brain Res. 801:1998;251-253.
12. McIntyre D.C., Nathanson D., Edson N. A new model of partial status epilepticus based on kindling. Brain Res. 250:1982;53-63.
13. Morrisett R.A., Jope R.S., Snead O.C. Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Exp. Neurol. 97:1987;193-200.
14. Racine R.J. Modification of seizure activity by electrical stimulation. Electroenceph. clin. Neurophysiol. 32:1972;281-294.
15. Vicedomini J.P., Nadler J.V. A model of status epilepticus based on electrical stimulation of hippocampal afferent pathways. Exp. Neurol. 96:1987;681-691.
16. Wasterlain C.G. Mortality and morbidity from serial seizures. Epilepsia. 15:1974;155-176.
17. Yaffe K., Lowenstein D.H. Prognostic factors for pentobarbital therapy for refractory generalized status epilepticus. Neurology. 43:1993;895-900.